Sign in
CompletedNo phase

Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure

Key facts

Who runs it
Charite University, Berlin, Germany
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
61 people enrolled
Started
23 Sept 2023
Ended
30 Jun 2024
Type of study
Observational
Treatments tested
  • Virtual Reality-based cue exposure paradigm
Record updated
26 August 2024

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (13)Hide the full registry criteria

Who can take part

  • age: 18-65 years
  • diagnosis of alcohol dependence according to ICD-10 (F10.2)
  • completed in-patient withdrawal treatment during the last 3 months
  • history of alcohol craving, confirmed via craving questionnaires
  • able to provide written informed consent

Who cannot take part

  • concurrent pharmacological treatment targeting AUD (i.e. benzodiazepines) or craving (i.e. acamprosate, disulfiram, naltrexone, nalmefene) and further medication significantly influencing heart frequency
  • severe neuropsychiatric disorder, e.g. schizophrenia spectrum disorders, bipolar affective disorder or substantial cognitive impairment
  • serious illnesses influencing brain-/heart-function with influence on physiological study parameters
  • substance dependence other than alcohol and nicotine
  • current alcohol intoxication (randomly tested via measurement of breath alcohol concentration)
  • unable to understand the study information, consent form or principles of the study
  • abstinence for less than 7 days or on-going consumption of alcohol
  • acute suicidality (or acute endangerment of others)

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Alcohol use disorder (AUD) is a burdensome clinical disorder with high relapse rates. Virtual Reality (VR)-based therapeutic and diagnostic approaches have received increasing attention in the treatment of AUD but evidence on the induction of craving via VR scenarios is still needed. Craving for alcohol is associated with psychological and physiological responses. This single-arm clinical study will be conducted including n=60 patients with AUD. Using a head-mounted display (HMD), patients will be confronted with three different VR scenarios (neutral vs. two target situations) while heart rate, heart rate variability (HRV), pupillometry and electrodermal activity (EDA) will be measured continuously. Subjective craving levels will be assessed pre-/during/post-exposure to each VR scenario.

Treatments tested

  • Virtual Reality-based cue exposure paradigm

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
26 August 2024